Medical Condition News

RSS

Majority of patients with ulcerative colitis eager to undergo fecal microbiota transplantation

The first study of the social and ethical issues associated with a provocative approach to treatment for ulcerative colitis has found that the majority of potential patients are eager for what is now called "fecal microbiota transplantation" to become available, although many have concerns about donor selection, screening, and methods of delivery.

3 Jun 2011

CICC White Paper identifies several care gaps of atrial fibrillation patients in Ontario

A White Paper released today by the Centre for Innovation in Complex Care (CICC), of the University Health Network (UHN), has identified significant care gaps of atrial fibrillation (AF) patients in Ontario, which contribute to debilitating strokes that could be prevented.

3 Jun 2011

Orexigen meets FDA to gain clarity on approval for Contrave NDA to treat obesity

Orexigen Therapeutics, Inc. announced today that it recently met with the Food and Drug Administration (FDA) regarding the New Drug Application for Contrave (naltrexone HCl/bupropion HCl) extended-release tablets for the treatment of obesity, including weight loss and maintenance of weight loss.

3 Jun 2011

Psychology researchers find interesting wrinkle in gambling decision- making process

Psychology researchers at the University of Alberta have found an interesting wrinkle in the decision- making process people use when gambling: People confronted with risky choices respond differently when they rely on past experiences, rather than when they just focus on the odds of winning or losing.

3 Jun 2011

UC review finds rate of rtPA treatment for ischemic stroke in the U.S. doubled since 2005

In a review of nationwide hospital databases, University of Cincinnati (UC) emergency medicine and neurology researchers have found that the rate of treatment with the standard therapy for acute ischemic stroke patients has doubled since 2005.

3 Jun 2011

Study to determine how vitamin D affects cardiac structure, functions in blacks with hypertension

A Wayne State University School of Medicine physician researcher has received a $1.9 million National Institutes of Health grant to study the role of vitamin D in halting and reducing subclinical cardiac damage in African-Americans suffering from high blood pressure.

3 Jun 2011

Pipeline Embolization Device safe and effective for patients with brain aneurysms

Physicians at Rush University Medical Center are offering a new and effective treatment to patients suffering from complex brain aneurysms. The recently FDA-approved technology called the Pipeline Embolization Device (PED) gives doctors the ability for the very first time to treat some of the most complex and dangerous brain aneurysms using minimally invasive techniques.

3 Jun 2011

New research aims to improve treatment of diabetes and cardiovascular diseases

New research at the University of Leicester to contribute to more effective drug design. A cutting-edge research project at the University of Leicester is aiming to improve the treatment of diabetes and cardiovascular diseases.

3 Jun 2011

QMUL synchronisation technology helps detect heart disease at early stage

Innovative UK technology is contributing to the development of a revolutionary digital stethoscope that could make it easier for GPs to spot the first signs of heart disease.

3 Jun 2011

Lung-sparing surgery, photodynamic therapy improve survival of mesothelioma patients

Pleural mesothelioma patients who undergo lung-sparing surgery in combination with photodynamic therapy (PDT) show superior overall survival than patient treated using the conventional therapy of extrapleural pneumonectomy (EPP) with PDT, indicates new research from the Raymond and Ruth Perelman School of Medicine at the University of Pennsylvania.

3 Jun 2011

Media outlets examine case of man cured of HIV, leukemia through bone marrow transplant

In a special report, Reuters examines the case of Timothy Ray Brown, who was cured of HIV and leukemia after undergoing "a bone marrow transplant using cells from a donor with a rare genetic mutation, known as CCR5 delta 32," which researchers knew conveyed resistance to HIV infection.

3 Jun 2011

New slow-release compound protects against Huntington's and Alzheimer's

A study in a special early online publication of Cell, a Cell Press publication, reveals a promising new slow-release compound that protects mice against the neurodegenerative effects of both Huntington's and Alzheimer's disease.

3 Jun 2011

Patch-clamp recording reveals subtle differences between two neurotransmitter-gated ion channels

Using a high-resolution single-molecule study technique, University of Illinois researchers have seen the very subtle differences between two branches of an important family of neurotransmitter-gated ion channels.

3 Jun 2011

New approach for identifying 'self' proteins targeted in autoimmune diseases

Researchers from Harvard Medical School and MIT have developed a new approach for identifying the "self" proteins targeted in autoimmune diseases such as multiple sclerosis, diabetes and rheumatoid arthritis.

3 Jun 2011

Teva completes patient enrollment in COPAXONE Phase III trial for treatment of multiple sclerosis

Teva Pharmaceutical Industries Ltd. today announced completion of patient enrollment for the GALA (Glatiramer Acetate Low-frequency Administration) trial.

3 Jun 2011

Hip strengthening exercises reduce patellofemoral pain, improve female runners' gaits

Hip strengthening exercises performed by female runners not only significantly reduced patellofemoral pain -- a common knee pain experienced by runners -- but they also improved the runners' gaits, according to Indiana University motion analysis expert Tracy Dierks.

3 Jun 2011

IMUC, BioWa sign license deal to develop ADCC enhanced antibodies for cancer

ImmunoCellular Therapeutics, Ltd. and BioWa, Inc. today announced that they have entered into a agreement to provide IMUC with access to BioWa's patented POTELLIGENT Technology platform for the development of antibody-dependent cellular cytotoxicity enhanced antibodies.

3 Jun 2011

Angiotensin receptor blockers do not increase risk of cancer: FDA

The U.S. Food and Drug Administration today announced that a group of medications used to control high blood pressure, called angiotensin receptor blockers (ARBs), do not increase the risk of developing cancer in patients using the medications.

3 Jun 2011

Study finds strong link between head injury and violent behavior in young people

Young people who have sustained a head injury during their lifetime are more likely to engage in violent behavior, according to an eight-year study from the University of Michigan School of Public Health.

3 Jun 2011

KGI scientists identify new gene regulator that keeps hearts healthy even under intense exercise

Providing a medical explanation for why exercise is good for the heart, a team of scientists from Brazil pursuing a study that started in Dr. Ian Phillips' lab at Keck Graduate Institute (KGI) has discovered a new gene regulator called MicroRNA 29 that keeps hearts healthy even under intense exercise.

3 Jun 2011

Medical Condition News

Majority of patients with ulcerative colitis eager to undergo fecal microbiota transplantation

CICC White Paper identifies several care gaps of atrial fibrillation patients in Ontario

Orexigen meets FDA to gain clarity on approval for Contrave NDA to treat obesity

Psychology researchers find interesting wrinkle in gambling decision- making process

UC review finds rate of rtPA treatment for ischemic stroke in the U.S. doubled since 2005

Study to determine how vitamin D affects cardiac structure, functions in blacks with hypertension

Pipeline Embolization Device safe and effective for patients with brain aneurysms

New research aims to improve treatment of diabetes and cardiovascular diseases

QMUL synchronisation technology helps detect heart disease at early stage

Lung-sparing surgery, photodynamic therapy improve survival of mesothelioma patients

Media outlets examine case of man cured of HIV, leukemia through bone marrow transplant

New slow-release compound protects against Huntington's and Alzheimer's

Patch-clamp recording reveals subtle differences between two neurotransmitter-gated ion channels

New approach for identifying 'self' proteins targeted in autoimmune diseases

Teva completes patient enrollment in COPAXONE Phase III trial for treatment of multiple sclerosis

Hip strengthening exercises reduce patellofemoral pain, improve female runners' gaits

IMUC, BioWa sign license deal to develop ADCC enhanced antibodies for cancer

Angiotensin receptor blockers do not increase risk of cancer: FDA

Study finds strong link between head injury and violent behavior in young people

KGI scientists identify new gene regulator that keeps hearts healthy even under intense exercise

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Latest News